AXSM Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-26 | 2022 | Mark Jacobson, M.A. Chief Operating Officer | 483,000 | 0 | 1,000,591 | 289,800 | 11,861 | 3,785,242 |
| 2024-04-26 | 2023 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 750,000 | 0 | 2,834,520 | 562,500 | 82,961 | 9,896,629 |
| 2024-04-26 | 2022 | Hunter Murdock, Esq. General Counsel | 450,000 | 0 | 577,503 | 270,000 | 15,388 | 2,484,699 |
| 2024-04-26 | 2023 | Hunter Murdock, Esq. General Counsel | 485,000 | 0 | 766,909 | 243,000 | 29,312 | 3,057,530 |
| 2024-04-26 | 2022 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 685,000 | 0 | 2,311,451 | 616,500 | 19,468 | 8,322,402 |
| 2024-04-26 | 2021 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 685,000 | 0 | 2,333,251 | 349,350 | 20,675 | 8,054,631 |
| 2024-04-26 | 2023 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 485,000 | 0 | 933,665 | 243,000 | 37,483 | 3,565,817 |
| 2024-04-26 | 2022 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 451,000 | 0 | 858,520 | 270,600 | 11,341 | 3,333,458 |
| 2024-04-26 | 2023 | Mark Jacobson, M.A. Chief Operating Officer | 530,000 | 0 | 1,067,077 | 265,000 | 40,837 | 4,036,250 |
| 2023-04-21 | 2021 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 409,000 | 0 | 866,617 | 139,060 | 5,910 | 4,228,710 |
| 2023-04-21 | 2020 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 575,000 | 0 | 1,615,860 | 448,500 | 0 | 7,304,689 |
| 2023-04-21 | 2021 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 685,000 | 0 | 2,333,251 | 349,350 | 20,675 | 8,054,631 |
| 2023-04-21 | 2022 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 685,000 | 0 | 2,311,451 | 616,500 | 19,468 | 8,322,401 |
| 2023-04-21 | 2021 | Hunter Murdock, Esq. General Counsel | 350,000 | 0 | 6,415 | 5,206 | 0 | 374,431 |
| 2023-04-21 | 2022 | Hunter Murdock, Esq. General Counsel | 450,000 | 0 | 577,503 | 270,000 | 15,388 | 2,484,699 |
| 2023-04-21 | 2021 | Mark Jacobson, M.A. Chief Operating Officer | 409,000 | 0 | 999,938 | 139,060 | 6,660 | 4,794,824 |
| 2023-04-21 | 2022 | Mark Jacobson, M.A. Chief Operating Officer | 483,000 | 0 | 1,000,591 | 289,800 | 11,861 | 3,785,242 |
| 2023-04-21 | 2022 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 451,000 | 0 | 858,520 | 270,600 | 11,341 | 3,333,458 |
| 2022-04-22 | 2020 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 575,000 | 0 | 1,615,860 | 448,500 | 0 | 7,304,690 |
| 2022-04-22 | 2021 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 685,000 | 0 | 2,333,251 | 349,350 | 20,675 | 8,054,631 |
| 2022-04-22 | 2020 | Mark Jacobson, M.A. Chief Operating Officer | 375,000 | 0 | 461,629 | 195,000 | 0 | 2,365,005 |
| 2022-04-22 | 2021 | Mark Jacobson, M.A. Chief Operating Officer | 409,000 | 0 | 999,938 | 139,060 | 6,660 | 4,794,824 |
| 2022-04-22 | 2020 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 375,000 | 0 | 461,629 | 195,000 | 0 | 2,365,005 |
| 2022-04-22 | 2021 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 409,000 | 0 | 866,617 | 139,060 | 5,910 | 4,228,710 |
| 2022-04-22 | 2019 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 435,000 | 0 | 0 | 326,250 | 0 | 4,715,753 |
| 2021-04-23 | 2020 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 575,000 | 0 | 1,615,860 | 448,500 | 0 | 7,304,690 |
| 2021-04-23 | 2019 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 435,000 | 0 | 0 | 326,250 | 0 | 4,715,753 |
| 2021-04-23 | 2018 | Herriot Tabuteau, M.D. Chief Executive Officer, President and Chairman of the Board | 435,000 | 0 | 0 | 261,000 | 0 | 1,057,425 |
| 2021-04-23 | 2020 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 375,000 | 0 | 461,629 | 195,000 | 0 | 2,365,005 |
| 2021-04-23 | 2019 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 325,000 | 0 | 0 | 195,000 | 0 | 1,569,837 |
| 2021-04-23 | 2018 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 203,125 | 15,000 | 0 | 156,000 | 0 | 687,981 |
| 2021-04-23 | 2020 | Mark Jacobson, M.A. Chief Operating Officer | 375,000 | 0 | 461,629 | 195,000 | 0 | 2,365,005 |
| 2021-04-23 | 2019 | Mark Jacobson, M.A. Chief Operating Officer | 310,000 | 0 | 0 | 162,750 | 0 | 1,955,681 |
| 2021-04-23 | 2018 | Mark Jacobson, M.A. Chief Operating Officer | 260,000 | 0 | 0 | 117,000 | 0 | 464,411 |
| 2021-04-23 | 2020 | David Marek Former Chief Commercial Officer | 385,000 | 0 | 392,387 | 0 | 544,375 | 2,455,147 |
| 2021-04-23 | 2019 | David Marek Former Chief Commercial Officer | 128,333 | 65,000 | 0 | 231,000 | 0 | 2,969,931 |
| 2020-04-21 | 2019 | Herriot Tabuteau, M.D. Chief Executive Officer and Chairman of the Board | 435,000 | 0 | 0 | 326,250 | 0 | 4,715,754 |
| 2020-04-21 | 2019 | David Marek Chief Commercial Officer | 128,333 | 65,000 | 0 | 231,000 | 0 | 2,969,931 |
| 2020-04-21 | 2018 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 203,125 | 15,000 | 0 | 156,000 | 0 | 687,981 |
| 2020-04-21 | 2019 | Nick Pizzie, C.P.A., M.B.A. Chief Financial Officer | 325,000 | 0 | 0 | 195,000 | 0 | 1,569,838 |
| 2020-04-21 | 2017 | Herriot Tabuteau, M.D. Chief Executive Officer and Chairman of the Board | 435,000 | 0 | 0 | 200,100 | 0 | 1,123,352 |
| 2020-04-21 | 2018 | Herriot Tabuteau, M.D. Chief Executive Officer and Chairman of the Board | 435,000 | 0 | 0 | 261,000 | 0 | 1,057,425 |
| 2019-04-26 | 2018 | Nick Pizzie, CPA, M.B.A. | 203,125 | 15,000 | 0 | 156,000 | 0 | 687,981 |
| 2019-04-26 | 2018 | Herriot Tabuteau, M.D. Chief Executive Officer and | 435,000 | 0 | 0 | 261,000 | 0 | 1,057,425 |
| 2019-04-26 | 2018 | John Golubieski Former Chief Financial Officer | 115,833 | 0 | 0 | 0 | 0 | 65,833 |
| 2019-04-26 | 2017 | John Golubieski Former Chief Financial Officer | 131,875 | 50,000 | 0 | 48,957 | 0 | 750,448 |
| 2019-04-26 | 2017 | Herriot Tabuteau, M.D. Chief Executive Officer and | 435,000 | 0 | 0 | 200,100 | 0 | 1,123,352 |
| 2018-04-30 | 2017 | Herriot Tabuteau, M.D. Chief Executive Officer and | 435,000 | 0 | 0 | 200,100 | 0 | 1,123,352 |
| 2018-04-30 | 2016 | Constance Ames Former Vice President, Finance | 225,000 | 0 | 0 | 53,325 | 0 | 409,769 |
| 2018-04-30 | 2016 | Herriot Tabuteau, M.D. Chief Executive Officer and | 435,000 | 0 | 0 | 174,000 | 0 | 3,364,067 |
| 2018-04-30 | 2017 | Constance Ames Former Vice President, Finance | 179,690 | 0 | 0 | 0 | 0 | 261,612 |
| 2018-04-30 | 2017 | John Golubieski | 131,875 | 50,000 | 0 | 48,957 | 0 | 750,448 |
| 2017-04-28 | 2015 | Herriot Tabuteau, M.D. Chief Executive Officer and Chairman of the Board | 300,000 | 150,000 | 0 | 0 | 0 | 450,000 |
| 2017-04-28 | 2015 | Constance Ames Vice President, Finance and Treasurer | 175,000 | 52,438 | 0 | 0 | 0 | 389,085 |
| 2017-04-28 | 2016 | Constance Ames Vice President, Finance and Treasurer | 225,000 | 53,325 | 0 | 0 | 0 | 409,769 |
| 2017-04-28 | 2015 | Randall Kaye, M.D. Former Chief Medical Officer | 126,667 | 50,805 | 0 | 0 | 0 | 705,055 |
| 2017-04-28 | 2016 | Randall Kaye, M.D. Former Chief Medical Officer | 273,333 | 0 | 0 | 0 | 0 | 273,333 |
| 2017-04-28 | 2016 | Herriot Tabuteau, M.D. Chief Executive Officer and Chairman of the Board | 435,000 | 174,000 | 0 | 0 | 0 | 3,364,067 |
| 2016-04-27 | 2014 | Herriot Tabuteau, M.D. Chief Executive Officer and Chairman of the Board | 250,000 | 125,000 | 0 | 0 | 0 | 375,000 |
| 2016-04-27 | 2015 | Herriot Tabuteau, M.D. Chief Executive Officer and Chairman of the Board | 300,000 | 150,000 | 0 | 0 | 0 | 450,000 |
| 2016-04-27 | 2015 | Constance Ames | 175,000 | 52,438 | 0 | 0 | 0 | 389,085 |
| 2016-04-27 | 2015 | Randall Kaye, M.D. | 126,667 | 50,805 | 0 | 0 | 0 | 705,055 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
